SARS CoV 2 News and Research

RSS

Study reveals why SARS-CoV-2 is more infectious than SARS-CoV-1

Researchers from China and Canada recently combined structural data obtained from cryo-EM and structure prediction and constructed bottom-up Martini coarse-grained models of intact envelopes of SARS-CoV and SARS-CoV-2.

22 Sep 2021

COVID-19 infection during pregnancy increases risk of developing pre-eclampsia, study finds

A newly published study found that women who contract COVID-19 during pregnancy are at significantly higher risk of developing pre-eclampsia, the leading cause of maternal and infant death worldwide.

22 Sep 2021

U.S. vaccination effort against COVID-19 needs intensifying, warn researchers

Researchers have warned that the United States has not yet reached the necessary thresholds for achieving population immunity against severe acute respiratory coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

22 Sep 2021

Researchers encourage longer dosing intervals for Pfizer-BioNTech’s COVID-19 vaccine

Researchers in Canada, Italy, and the United States have encouraged extending the interval time between two doses of Pfizer-BioNTech’s coronavirus disease 2019 (COVID-19) vaccine among individuals who have not previously been infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

22 Sep 2021

Pregnant women who receive COVID-19 vaccine pass high levels of antibodies to their babies

Women who receive the mRNA COVID-19 vaccine during pregnancy pass high levels of antibodies to their babies, a new study finds.

22 Sep 2021

mRNA-based and adenoviral vector-based COVID-19 vaccines elicit diverse humoral immunity

Scientists from the USA have recently compared the dynamics of humoral and cellular immune responses induced by mRNA-based and adenoviral vector-based coronavirus disease 2019 (COVID-19) vaccines. The findings reveal a difference in humoral immune responses. The study is currently available on the medRxiv* preprint server.

22 Sep 2021

The importance of handwashing in the COVID-19 era: Back to basics

Researchers from the United States have reviewed the different components of formulated soaps and their performance as cleansers and pathogen inactivators, the criticality of the time spent hand washing, the relationships between water temperature and pathogen inactivation.

22 Sep 2021

Pinning down Pin1: Potential COVID-19 therapy

In a recent study scientists have demonstrated that Pin1 is one of the key cellular molecules necessary for SARS-CoV-2 propagation.

22 Sep 2021

The role of nanomaterials during the COVID-19 pandemic

A new review published in Rare Metals has focused on the applications of nanomaterials to fight the ongoing COVID-19 pandemic.

22 Sep 2021

Hypertonic saline solution shown to inhibit replication of SARS-CoV-2

Researchers at the University of São Paulo (USP) in Brazil have shown that a hypertonic saline solution inhibits replication of SARS-CoV-2, the virus that causes COVID-19, and have elucidated the biochemical mechanism involved.

22 Sep 2021

COVID-19 vaccination in IBD patients

In this review, researchers reviewed all published research related to Phase 1/2 and/or Phase 3 and 4 studies of SARS-CoV-2 vaccinations.

22 Sep 2021

Unique tiny Ilamas antibodies could be used for treatment of COVID-19

A unique type of tiny antibody produced by llamas could provide a new frontline treatment against Covid-19 that can be taken by patients as a simple nasal spray.

22 Sep 2021

SARS-CoV-2 genome signature leads to replicative advantage in presence of Remdesivir

A new study indicates that low-level resistance of SARS-CoV-2 to remdesivir is not widespread and dissimilar to other RNA viruses revealing evolutionary predictability of this pandemic virus.

22 Sep 2021

Evidence for safety of Pfizer-BioNTech’s COVID-19 vaccine booster dose

Researchers have conducted a study demonstrating the safety of administering a third (booster) dose of Pfizer-BioNTech’s BNT162b2 vaccine.

22 Sep 2021

SARS-CoV-2 delta variant has higher viral RNA levels and increased infectivity, suggests study

The study found that the delta and epsilon variants exhibited significantly higher infectivity than alpha, with delta containing approximately six times as much infectious virus for the same amount of RNA.

22 Sep 2021

New framework needed to explore links between evolved pathogen tolerance and emerging infections

A new multidisciplinary research framework is needed to explore links between evolved tolerance to pathogens and their spillover into humans, scientists write today in the journal eLife.

22 Sep 2021

COVID-19 deaths in U.S. surpass 1918 Spanish Flu pandemic

The coronavirus disease (COVID-19) pandemic is most likely the deadliest outbreak in recent American history, exceeding the estimated deaths from the 1918 influenza pandemic.

21 Sep 2021

Those undergoing treatment for hematological malignancies show reduced immune response to COVID-19 vaccines

Researchers recently investigated the effect of infection with SARS-CoV-2 in patients with hematologic malignancies in minority populations.

21 Sep 2021

Severe tinnitus following SARS-CoV-2 infection

A 49-year-old male with a history of COVID-19 presents with tinnitus.

21 Sep 2021

Oxford COVID vaccine technology has the potential to revolutionize cancer treatment

Scientists from the University of Oxford and the Ludwig Institute for Cancer Research are building on the success of the Oxford-AstraZeneca vaccine against SARS-CoV-2 to develop a vaccine to treat cancer.

21 Sep 2021

SARS CoV 2 News and Research

Study reveals why SARS-CoV-2 is more infectious than SARS-CoV-1

COVID-19 infection during pregnancy increases risk of developing pre-eclampsia, study finds

U.S. vaccination effort against COVID-19 needs intensifying, warn researchers

Researchers encourage longer dosing intervals for Pfizer-BioNTech’s COVID-19 vaccine

Pregnant women who receive COVID-19 vaccine pass high levels of antibodies to their babies

mRNA-based and adenoviral vector-based COVID-19 vaccines elicit diverse humoral immunity

The importance of handwashing in the COVID-19 era: Back to basics

Pinning down Pin1: Potential COVID-19 therapy

The role of nanomaterials during the COVID-19 pandemic

Hypertonic saline solution shown to inhibit replication of SARS-CoV-2

COVID-19 vaccination in IBD patients

Unique tiny Ilamas antibodies could be used for treatment of COVID-19

SARS-CoV-2 genome signature leads to replicative advantage in presence of Remdesivir

Evidence for safety of Pfizer-BioNTech’s COVID-19 vaccine booster dose

SARS-CoV-2 delta variant has higher viral RNA levels and increased infectivity, suggests study

New framework needed to explore links between evolved pathogen tolerance and emerging infections

COVID-19 deaths in U.S. surpass 1918 Spanish Flu pandemic

Those undergoing treatment for hematological malignancies show reduced immune response to COVID-19 vaccines

Severe tinnitus following SARS-CoV-2 infection

Oxford COVID vaccine technology has the potential to revolutionize cancer treatment

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News